ADA. Jane Dickinson

A. Jane Dickinson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


A. Jane Dickinson has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Orbital lymphatics: do they exist?

    by A J Dickinson, R E Gausas

    Eye is the official journal of the Royal College of Ophthalmologists. It aims to provide the practising ophthalmologist with information on the latest clinical and laboratory-based research.


  • Open Access

    A Modified Method for Measuring Uniocular Fields of Fixation

    by Helen Haggerty, Sarah Richardson, Keith W. Mitchell, A. Jane Dickinson

    In assessing restricted eye movements in patients, the measurement of monocular excursions (ductions) remains essential. In the clinical setting, ductions are commonly graded using simple scales, eg, −4 to 0 to 4. Such methods are, however, prone to standardization errors and are less suitable for accurate quantification. This is particularly true in Graves orbitopathy (GO), in which quantified motility change is an important outcome measure.1,2 The most common techniques for measuring monocular excursions use an arc or a Goldmann perimeter. Excursions are measured along 4 to 12 directions of gaze to produce a uniocular field of fixation (UFOF).1,3-6 Measurement in all meridians on a perimeter5 is time consuming and tiring and uncomfortable for the patient, and hence potentially inaccurate. Conversely, assessment limited to 4 directions of gaze (0°, 90°, 180°, and 270°)1,6 can be performed rapidly, but interpretation of individual vertical muscles is limited. In particular, small but significant changes in inferior rectus restriction commonly seen in GO may be less apparent if upgaze in abduction is not assessed.


  • Open Access

    The use of porous polyethylene (Medpor) lower eyelid spacers in lid heightening and stabilisation

    by J Tan, J Olver, M Wright, R Maini, C Neoh, A J Dickinson

    Background/aims: The management of lower eyelid retraction can be challenging, and established techniques to correct it are not always successful. Previous reports have suggested a role for the ultrathin high density porous polyethylene lower eyelid spacer (Medpor LES) in such patients. The authors report the experience of three surgeons implanting Medpor LES over 1 year, and ascertain whether such implants are a safe and effective alternative to autogenous spacers. Methods: A prospective, interventional, non-comparative case series of consecutive patients. Surgical indications for Medpor LES were noted. Preoperative and postoperative lower marginal reflex distance (L-MRD), vertical palpebral aperture (PA), lagophthalmos, and scleral show inferior to the limbus (LSS) were recorded, together with major and minor complications. Results: 32 patients (35 eyelids) had a Medpor LES inserted, 22/32 under local anaesthetic, and nine with adjunctive procedures. Mean follow up was 22 months (range 15–28 months). The Medpor LES was effective in reducing the palpebral aperture (pConclusions: Despite a good or satisfactory final outcome in the majority of patients, the value of this technique is limited by complications, and should be reserved for those unsuitable for safer techniques.


  • Open Access

    Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment

    by A. Jane Dickinson, Petros Perros

    Despite many learned publications over recent decades, the assessment of active thyroid‐associated orbitopathy (TAO) remains difficult and controversial. There are no biochemical, immunological or imaging investigations which can identify active disease reliably, and clinical assessment is still of paramount importance. We therefore review the strengths and weaknesses of all methods of clinical assessment. A new atlas for clinical assessment of soft tissue signs has been developed, and its reproducibility assessed. It details a suggested protocol that could help standardize descriptions of TAO and allow more objective assessment of its activity and severity. This is relevant to general endocrinologists, who have a crucial role in the identification of patients who require ophthalmological assessment. Certain aspects are more relevant to ophthalmologists and endocrinologists who have a special clinical and research interest in TAO. Unless a reproducible system of assessment is devised and widely adopted, it will remain difficult to interpret research meaningfully, particularly if results appear to contradict.